Loading...
ZEXA CARE Series
Header Background Header Background ONE TRILLION Logo

The Era of Quantifiable Beauty Has Arrived

One Trillion product

Anti-aging Carewith Exosomes

Redefining beauty standards.
ONE TRILLION unlocks
your skin's natural potential.

Premium high-concentration exosomes
lead you to unprecedented beauty.

A masterpiece born from cutting-edge technology.
Awaken your skin's dormant beauty
with ONE TRILLION

Redefining beauty standards.
ONE TRILLION unlocks your potential.

Premium high-concentration exosomes
awaken your skin's dormant beauty

Industry's Highest Concentration

ONE TRILLION exosomes

Our supernatant achieves superior concentration through our technology and experience.
The excellence of this product is backed by our research team's cutting-edge expertise.
Additionally, our cell processing center's independently developed automated culture system significantly contributes to product quality enhancement.

Our supernatant achieves
superior concentration compared to competitors.
The excellence of this product is backed by our research team's cutting-edge expertise.

item

Exosome Content in ONE TRILLION

1,000,000,000,000 (1 Trillion)
Floating image 1 Floating image 2 Floating image 3

What are Exosomes?

They promote improvement in tissues with reduced function

ONE TRILLION's 8 Approaches

  • Moisture
  • Pigmentation
  • Pores
  • Brightness
  • Firmness
  • Translucency
  • Radiance
  • Elasticity

ONE TRILLION's Four Strengths

The Four Core Advantages of ONE TRILLION

Concentration image

Strength 1

Unparalleled Concentration

Successfully concentrated to 50 billion/1ml of exosomes. While typical exosome products contain 1 billion units, we've achieved approximately 50 times concentration through our innovative automated supernatant/fractionation

Research team image

Strength 2

Distinguished Research Team

We maintain strong partnerships with leading research institutions and medical facilities globally and professors with exceptional achievements in various fields. This enables us to integrate cutting-edge technology and knowledge.

Cultivation system image

Strength 3

Auto-Cultivation System

Our equipment processes 10,000ml+ of supernatant material simultaneously for mass production. Unlike conventional systems with 80% impurities, our technology minimizes impurities like lactic acid and ammonia.

Quality assurance image

Strength 4

Highest Quality Assurance

Our cell processing center, equipped with GMP-standard compliant facilities and skilled technical team, achieves both quality. Our stable production system ensures continuous supply of high-quality products, meeting diverse needs.

Cell Processing Center: Excellence in Quality and Production

Advanced Processing Facility Ensuring Premium Quality

01 Cell Processing Center

Our in-house laboratory serves as a research and development hub for deciduous tooth pulp-derived exosome supernatant. We operate in accordance with facility management standards.

Cell Processing Center

02 "Ella" Four-Type Cytokine Measurement System

Our laboratory houses equipment capable of simultaneously measuring four types of cytokines in our "High-Concentration Factor 9." This high-grade testing equipment ensures quality through precise measurements.

Ella Measurement System

*"Ella" Cytokine Measurement System (Market value: 10 million yen)

03 Original Automated Cultivation System

Our proprietary automated cultivation system enables mass production. This machine can process over 10,000mL of supernatant raw material in a single batch.

Automated Cultivation System

*Image is for illustration only (AI-generated). Actual system cannot be shown due to trade secrets.

04 "NanoSight Pro" Exosome Particle Analysis System

This system measures the quantity of exosomes in our "High-Concentration Factor 9." Using Nanoparticle Tracking Analysis (NTA), it analyzes particles based on their Brownian motion speed according to particle size. Our cell processing center can measure both cytokines and exosomes.

NanoSight Pro System

*"NanoSight Pro" Exosome Measurement System (Market value: 25 million yen)

On Human Stem Cells and Dental Pulp Stem Cells from Deciduous Teeth

About Human Stem Cells and Deciduous Tooth Pulp Stem Cells

What are Human Stem Cells?

They are miraculous regenerative medicine capable of regenerating body tissues and organs. Due to this "multipotency" and "self-renewal ability," human stem cells are drawing significant attention in medical, cosmetic, and research fields.

Deciduous Tooth Pulp Stem Cells

Among various stem cell sources like fat and bone marrow, deciduous tooth pulp stem cells offer the highest growth factor concentration. They show promise in tissue regeneration and treating chronic diseases.

Exceptionally High Concentration and Quality

Achieving 10+ Times the Concentration and Quality

VEGF Comparison Graph
HGF Comparison Graph
IL-6 Comparison Graph
MCP1 Comparison Graph

Exceptionally High Concentration and Quality

Achieving 10+ Times the Concentration and Quality

At our company, we manufacture exosome supernatant using proprietary purification technology and special cell culture methods. Through this approach, we focus on developing products with controlled concentration and quality.

VEGF: 90,405 pg/mL

HGF: 40,320 pg/mL

MCP-1: 6,831 pg/mL

IL-6: 9,428 pg/mL

bFGF: 2,743 pg/mL

Exosomes: 50 billion/mL

Lactic acid: 20 mg/dL

Ammonia: 5 μg/dL

Cells Contained in Exosomes and Their Roles

Introduction to Some Key Cytokines
in Exosome Supernatant

*Click each icon to learn about their roles

Let's do fem care & homme care

The Vagina is Your Second FaceLet's Practice Fem Care

Let's do homme care

The Scrotum is Your Second FaceLet's Practice Homme Care

Alliance Partners

Medical Advisors

Honorary Technical Advisor Nobuo Kitazato

iPS BANK NFT
Guardians Club

Honorary Chairman Nobuo Kitazato

May 2020
Founded the Japan Infectious Disease Control Association,
providing information and support for infectious disease measures,
focusing on COVID-19
Appointed as director
Great-grandson of bacteriologist Shibasaburo Kitasato

Honorary Chairman Minoru Ueda

iPS BANK NFT
Guardians Club

Honorary Technical Advisor Minoru Ueda
  • 1949 Born in Osaka Prefecture
  • 1984 Completed Doctoral Program at Nagoya University Graduate School of Medicine, Ph.D.
  • 1990 Associate Professor at Nagoya University School of Medicine
  • 1990 Visiting Researcher at University of Gothenburg (Sweden)
  • 1991 Visiting Researcher at University of Zurich (Switzerland)
  • 1994 Professor at Nagoya University School of Medicine (Oral Surgery)
  • 2000 Professor at Nagoya University Graduate School of Medicine (Head and Neck Sensory Surgery)
  • 2001 Board Member of Japanese Society for Regenerative Medicine
  • 2003 Visiting Professor at The Institute of Medical Science, The University of Tokyo
  • 2011 Visiting Professor at University of Bergen (Norway)
  • 2015 Professor Emeritus at Nagoya University School of Medicine
  • 2016 Evaluation Committee Member of Japan Agency for Medical Research and Development (AMED)
Chief Medical Technical Advisor Tomohiro Myojo

iPS BANK NFT
Guardians Club

Chief Medical Technical Advisor Tomohiro Myojo
  • ■Qualifications Japanese Society of Internal Medicine Certified Physician, Japanese Society of Medical Oncology Board Certified Medical Oncologist and Supervisor, Japanese Society of Hematology Board Certified Hematologist and Supervisor, Japanese Society of Chemotherapy Certified Physician and Supervisor in Antimicrobial Chemotherapy, Japanese Society of Cancer Therapy Board Certified Member, ICD (Infection Control Doctor), Total Nutritional Therapy Completed
  • ■Specializations Cancer Drug Therapy (Chemotherapy), Blood Disorders (Benign and Malignant), Infection Control, Immunotherapy
  • 2001 Graduated from Kumamoto University School of Medicine
  • 2001 Department of Medicine, Kidney/Immune/Endocrine/Metabolic Internal Medicine, Okayama University Hospital
  • 2001 Internal Medicine, Kure Mutual Aid Hospital
  • 2003 Hematology Department, Kure Mutual Aid Hospital
  • 2004 Department of Hematology, Toranomon Hospital
  • 2005 Departments of Chemotherapy and Hematology Oncology, Cancer Institute Hospital
  • 2009 Department of Oncology and Hematology, Edogawa Hospital
  • 2009 Chief Physician
  • 2012 Deputy Director
  • 2012 Director of Infection Control Department
  • 2016 Director of Tokyo Cancer Immunotherapy Center (concurrent position)
  • 2016 Appointed as Hyper Medical Creator
  • 2018 Director of Precision Medicine Center (concurrent position)
  • 2020 Director of Department of Oncology and Hematology, Edogawa Hospital
  • 2024 Vice Director of Edogawa Hospital

Exosome Supernatant: Our Commitment to Innovative Research and Development

ZEXAVERSE logoZEXAVERSE is a company dedicated to exosome supernatant research and development

ZEXAVERSE Inc. is a company researching and developing blockchain technology and metaverse solutions to enhance "Quality of Life."
We contribute to SDGs through initiatives utilizing cutting-edge technologies such as "Metaverse," "WEB3.0," "3D scanning," and "Drones."
ZEXAVERSE Inc. develops blockchain, metaverse, and NFT-related systems that will be crucial for future industries and lifestyle.
Using drone technology, we support various industrial challenges in agriculture, logistics, and infrastructure inspection, revolutionizing industries from the sky.
Additionally, using metaverse technology, we create educational spaces where people worldwide can connect without time or location constraints, contributing to equal and high-quality educational opportunities.
Our metaverse development serves as a bridge between the physical and digital worlds, creating new solutions for sustainability issues and contributing to improving people's quality of life globally.

ZEXAVERSEhttps://zexaverse.co.jp/

ZEXAVERSE TOKYOhttps://zexaverse.tokyo/